Next-gen diagnostics, genomics, and specialty care leaders.
Investments in securities market are subject to market risks. Past performance is not indicative of future results. Curated baskets are for informational purposes.
| Stock | Thesis & Rationale |
|---|---|
| SUNPHARMA 25% Weight | Deep specialty portfolio in the US and global markets. |
| APOLLOHOSP 25% Weight | Largest healthcare ecosystem with massive AI adoption in diagnostics. |
| MAXHEALTH 20% Weight | Efficiency leader with high-growth premium hospital assets. |
| SYNGENE 15% Weight | Global leader in specialized research and contract manufacturing. |
| METROPOLIS 15% Weight | Pioneer in tech-led widespread diagnostic testing. |